Phenotypic characteristics and outcomes of late-onset urea cycle disorders
Nội dung chính của bài viết
Tóm tắt
Urea cycle disorders (UCD) are characterized by elevated blood ammonia levels due to deficiencies in enzymes essential for urea metabolism. Early diagnosis and treatment reduce mortality and sequelae. Objective: To describe the phenotypic characteristics and treatment outcomes of late-onset UCD from 2010 to September 2021. Results: 32 patients from 27 families with a median age of onset of 30 months old (range: 2-180 months). 33.3% of patients had a relevant family history. Reasons for medical consultation included vomiting, fatigue/poor appetite, and lethargy. Clinical presentation upon admission: 68.8% had impaired consciousness, 75% exhibited vomiting and poor appetite, 15% experienced seizures, and 6.2% presented with muscle tone disorders. Laboratory findings showed hyperammonemia in 93.8% of cases, with elevated lactate, increased liver enzymes, and decreased prothrombin time in 87.5% of patients. Treatment with ammonia-lowering medications, hemodialysis, and glucose infusion successfully saved 87.5% of patients. Conclusion: Blood ammonia testing is essential in patients with altered consciousness, elevated liver enzymes, and decreased prothrombin time. Glucose infusion, ammonia-lowering medications, and hemodialysis demonstrate favorable outcomes.
Urea cycle disorders (UCD) are characterized by elevated blood ammonia levels due to deficiencies in enzymes essential for urea metabolism. Early diagnosis and treatment reduce mortality and sequelae. Objective: To describe the phenotypic characteristics and treatment outcomes of late-onset UCD from 2010 to September 2021. Results: 32 patients from 27 families with a median age of onset of 30 months (range: 2-180 months). 33.3% of patients had a relevant family history. Reasons for medical consultation included vomiting, fatigue/poor appetite, and lethargy. Clinical presentation upon admission: 68.8% had impaired consciousness, 75% exhibited vomiting and poor appetite, 15% experienced seizures, and 6.2% presented with muscle tone disorders. Laboratory findings showed hyperammonemia in 93.8% of cases, with elevated lactate, increased liver enzymes, and decreased prothrombin time in 87.5% of patients. Treatment with ammonia-lowering medications, hemodialysis, and glucose infusion successfully saved 87.5% of patients. Conclusion: Blood ammonia testing is essential in patients with altered consciousness, elevated liver enzymes, and decreased prothrombin time. Glucose infusion, ammonia-lowering medications, and hemodialysis demonstrate favorable outcomes.
Chi tiết bài viết
Từ khóa
Urea cycle disorders
Tài liệu tham khảo
2. Uchino T, Endo F, Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis. 1998;21 Suppl 1:151-159. doi:10.1023/a:1005374027693
3. Martín-Hernández E, Aldámiz-Echevarría L, Castejón-Ponce E, et al. Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases. Orphanet J Rare Dis. 2014;9:187. doi:10.1186/s13023-014-0187-4
4. Wells DL, Thomas JB, Sacks GS, et al. Late-onset urea cycle disorder in adulthood unmasked by severe malnutrition. Nutr Burbank Los Angel Cty Calif. 2014;30(7-8):943-947. doi:10.1016/j.nut.2013.12.011
5. Summar ML, Dobbelaere D, Brusilow S, et al. Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr Oslo Nor 1992. 2008;97(10):1420-1425. doi:10.1111/j.1651-2227.2008.00952.x
6. Nguyen Thanh Hong. Nghien cuu dac diem dich te hoc lam sang va ket qua dieu tri benh roi loan chuyen hoa chu trinh ure o tre em. Hanoi Medical University. 2015.
7. Ah Mew N, Simpson KL, Gropman AL, et al. Urea Cycle Disorders Overview. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. University of Washington, Seattle; 1993. Accessed April 11, 2025. http://www.ncbi.nlm.nih.gov/books/NBK1217/
8. Saritaş Nakip Ö, Yıldız Y, Tokatlı A. Retrospective evaluation of 85 patients with urea cycle disorders: one center experience, three new mutations. J Pediatr Endocrinol Metab JPEM. 2020;33(6):721-728. doi:10.1515/jpem-2019-0413
9. Jalan A, Häberle J, Kudalkar K, et al. Survival and outcome of patients with urea cycle disorders: a single-center experience. Perinatology. 2016;17(3):110-119. doi:10.5167/uzh-132060
10. Häberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis. 2019;42(6):1192-1230. doi:10.1002/jimd.12100
11. Arbeiter AK, Kranz B, Wingen AM, et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2010;25(4):1257-1265. doi:10.1093/ndt/gfp595
12. Picca S, Dionisi-Vici C, Abeni D, et al. Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol Berl Ger. 2001;16(11):862-867. doi:10.1007/s004670100702